Document Detail

Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.
MedLine Citation:
PMID:  20108129     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Description of the cutaneous side effects of erlotinib.
MATERIALS: Report with images of a single case.
METHODS: Case report and review of the literature.
CONCLUSION: Erlotinib is associated with significant cutaneous toxicity which should be recognised and managed appropriately.
P Forde; C Murphy; C O'Sullivan; D Carney
Related Documents :
9257349 - Cutaneous leishmaniasis in libya: epidemiological survey in al-badarna.
21634669 - News from pittcon: big plans for 50th.
12041549 - Lymphatic leishmaniasis--first case report from nepal.
15186229 - Cardio-facio-cutaneous syndrome: report of a case with a review of the literature.
15008879 - Cutaneous seeding of hepatocellular carcinoma due to percutaneous ethanol injection and...
8481999 - Erosive, flexural lichen planus--an uncommon variant.
17933079 - Tips and tricks to make case report.
24744569 - Unique paradoxical atlantoaxial dislocation with c1-c2 facet diastases and isolated lig...
23124539 - Achieving a key purpose.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-01-28
Journal Detail:
Title:  Irish journal of medical science     Volume:  180     ISSN:  1863-4362     ISO Abbreviation:  Ir J Med Sci     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-01-21     Completed Date:  2011-06-16     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  7806864     Medline TA:  Ir J Med Sci     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  283-4     Citation Subset:  IM    
Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenocarcinoma / drug therapy*
Alopecia / chemically induced*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Eyelashes / drug effects
Hypertrichosis / chemically induced*
Lung Neoplasms / drug therapy*
Middle Aged
Quinazolines / adverse effects*,  therapeutic use*
Receptor, Epidermal Growth Factor / antagonists & inhibitors*
Reg. No./Substance:
0/Quinazolines; EC, Epidermal Growth Factor; J4T82NDH7E/erlotinib

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  An effective method for the quantitative detection of porcine endogenous retrovirus in pig tissues.
Next Document:  Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sy...